KR840000483A - 유기화합물의 개량 - Google Patents

유기화합물의 개량 Download PDF

Info

Publication number
KR840000483A
KR840000483A KR1019820002722A KR820002722A KR840000483A KR 840000483 A KR840000483 A KR 840000483A KR 1019820002722 A KR1019820002722 A KR 1019820002722A KR 820002722 A KR820002722 A KR 820002722A KR 840000483 A KR840000483 A KR 840000483A
Authority
KR
South Korea
Prior art keywords
alkyl
compound
general formula
unsubstituted
substituted
Prior art date
Application number
KR1019820002722A
Other languages
English (en)
Other versions
KR890000622B1 (ko
Inventor
리차드 베이커 스테펜 (외 3)
Original Assignee
테렌스 로저 크로우더
릴리 인더스트리스 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 테렌스 로저 크로우더, 릴리 인더스트리스 리미티드 filed Critical 테렌스 로저 크로우더
Publication of KR840000483A publication Critical patent/KR840000483A/ko
Application granted granted Critical
Publication of KR890000622B1 publication Critical patent/KR890000622B1/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B45/00Formation or introduction of functional groups containing sulfur
    • C07B45/04Formation or introduction of functional groups containing sulfur of sulfonyl or sulfinyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/44Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C07C317/46Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/22Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/56Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/38Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D303/40Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by ester radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/38Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D303/40Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by ester radicals
    • C07D303/42Acyclic compounds having a chain of seven or more carbon atoms, e.g. epoxidised fats
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30Oxygen atoms, e.g. delta-lactones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D313/00Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02Seven-membered rings
    • C07D313/04Seven-membered rings not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/50Organo-phosphines
    • C07F9/53Organo-phosphine oxides; Organo-phosphine thioxides
    • C07F9/5304Acyclic saturated phosphine oxides or thioxides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/50Organo-phosphines
    • C07F9/53Organo-phosphine oxides; Organo-phosphine thioxides
    • C07F9/5325Aromatic phosphine oxides or thioxides (P-C aromatic linkage)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

내용 없음

Description

유기화합물의 개량
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (6)

  1. 다음 일반식(Ⅰ)으로 표시되는 유리산 형태인 화합물을 제조하는 방법에 있어서,
    (상기식에서, (ⅰ) 할로겐, 히드록시, C3-6알콕시, C3-6시클로알킬, 아릴 또는 헤테로 아릴로부터 선택한 최소한 하나의 치환분에 의하여 치환 또는 비치환된 20개 까지의 탄소원자를 갖는 지방족, 포화 또는 불포화 하이드로카르빌기이고, 시클로알킬, 아릴 또는 헤테로 아릴은 히드록시, 할로겐과 10개 까지의 탄소원자를 갖는 알킬, 알케닐 또는 알키닐로 부터 선택한 최소한 하나의 치환분에 의하여 치환 또는 비치환 된다. (ⅱ) 16개 까지의 탄소원자를 갖는 알킬, 알케닐 또는 알키닐에 의하여 치환 또는 비치환된 3-8개의 탄소원자를 갖는 시클로알킬 (ⅲ) 히드록실, C1-4알콕시, 할로겐 또는 16개까지의 탄소원자를 갖는 알킬, 알케닐 또는 알키닐에 의하여 치환 또는 비치환된 아릴 또는 헤테로 알릴이고;
    R2는 (ⅰ) 아릴, 시클로알킬, 할로겐, 히드록시, NHR3와 COX로 부터 선택된 하나 또는 그 이상의 치환분에 의하여 치환 또는 비치환된 10개 까지의 탄소원자를 갖는 알킬, 시클로알킬, 또는 알케닐, 여기서 R3는 수소, C1-4알킬, 아릴, 아미노산 잔기 또는 COX이고 X는 OH, C1-4알킬, NH2또는 아미노산잔기이다. (ⅱ) C1-4알킬, C1-4알콕시, C12-5아실, 할로겐, 히드록시 카르복시, 니트로, 트리할로 메틸, 페닐, C1-4아실하미노와 NHR4로 부터 선택한 하나 또는 그 이상의 치환분에 의하여 치환 또는 비치환된 아릴 또는 헤테로아릴이고, 여기서는 수소 또는 C1-4알킬이며; Y는 -S-, -SO- 또는 -SO2-이다. 이때 -YR2가 글루타티오닐, 시스테이닐 또는 시스테이닐글리시닐이면, R1은 12-16개의 탄소원자를 갖는 비치환 알카테트라에틸 또는 알카펜타에닐기 이와의 것이다)
    a) Y가 -S-인 유리산 형태의 일반식(Ⅰ)으로 표시되는 화합물은 ai) 다음 일반식(Ⅱ)으로 표시되는 유리산 형태인 화합물.
    (여기서 R1은 상술한 바와 같다)을 불활성 용매의 존재하에 다음 일반식(Ⅲ)의 염화 설페닐;
    R2SCl (Ⅲ)
    (상기식에서 R2는 상술한 바와 같다)과 반응시켜서 제조하고, 생성된 일반식(Ⅰ)으로 표시되는 화합물의 락튼을 단리시키거나 아니면 유리산 형태의 일반식(Ⅰ)으로 표시되는 화합물을 얻기 위하여 생성된 락튼을 가수분해 한다. aⅱ) 다음 일반식(Ⅳ)으로 표시되는 유리산 형태인 화합물;
    (여기서 R는 상술한 바와 같다)을 다음 일반식(Ⅴ)의 티올;
    R2SH (Ⅴ)
    (여기서 R2는 상술한 바와 같다)과 반응시켜서 제조한다. b) Y가 -S-인 상기의 일반식(Ⅰ)으로 표시되는, 유리산 형태인 대응하는 화합물을 산화시켜서 Y가 -SO- 또는 -SO2-인 상기 일반식(Ⅰ)으로 표시되는 유리산 형태인 화합물을 제조하며; c) 다음 일반식(Ⅵ)의 화합물;
    R1-CH2-SO2R2(Ⅵ)
    (여기서 R1과 R2는 상술한 바와 같다)을 다음 일반식(Ⅳ)으로 표시되는 유리산 형태의 화합물;
    과 반응시켜서 Y가 -SO2-인 일반식(Ⅰ)으로 표시되는 유리산형태의 화합물을 제조하고, 필요하면 유리산, 락톤, 염, 또는 에스테르 형태의 생성된 화합물을 단리시켜서 제조함블 특징으로 하는 일반식(Ⅰ)으로 표시되는 화합물의 제조방법.
  2. 청구범위 1에 있어서, R1이 청구범위 1에 언급한 (ⅰ) 또는 (ⅱ) 또는 (ⅲ)히드록실, 할로겐 또는 16개 까지의 탄소 원자를 갖는 알킬, 아케닐 또는 알키닐에 의하여 치환 또는 비치환된 아릴 또는 헤테로 아릴이고; R2가 (ⅰ)아릴, 할로겐, 히드록시, NHR3과 COX로 부터 선택한 하나 또는 그 이상의 치환분에 의하여 치환 또는 비치환된, 10개까지의 탄소원자를 갖는 알킬, 또는 알케닐, (여기서 R3는 수소, C1-4알킬, 알릴, 아미노산 잔기 또는 COX이고, X는 OH 또는 아미노산잔기이다.) 또는 (i)C1-4알킬, C1-4알콕시, 할로겐, 히드록시, 카르복시와 NHR4(여기서 R4는 수소 또는 C1-4알킬)로부터 선택된 하나 또는 그 이상의 치환분에 의하여 치환 또는 비치환 된 아릴 또는 헤테로 아릴임을 특징으로 하는 일반식(Ⅰ)의화합물의 제조방법.
  3. 다음 일반식의 청구범위 1에 있어서,
    상기식에서 아릴, 시클로알킬, 할로겐, 히드록시, NHR3와COX로부터 선택한 하나 또는 그 이상 치환 또는 비치환된, 10개까지의 탄소원자를 갖는 알킬, 시클로알킬 또는 알케닐이고(여기서 R3는 C1-4알킬, 아릴, 아미노산 잔기 또는 COX이고, X는 OH, C1-4알킬, NH2또는 아미노산잔기이다). R5는 3-14개의 탄소원자를 갖는 알킬 또는 알케닐 이고, 알케닐기는 식 R7CH=CH-(여기서 R7은 C1-12알킬) 또는 페닐, 나프틸이고, R6가 수소 또는 C1-4알킬임을 특징으로 하는 상기 일반식의 화합물과, 이의 락톤, 염과 에스테르형태인 화합물의 제조방법.
  4. 다음 일반식으로 표시되는 청구범위 1의 화합물에 있어서,
    상기식에서 R1이 치환 또는 비치환 페닐 또는 나프틸 또는 식 R5-CH∥CH-의 기(여기서 R5는 페닐, 벤질 또는 나프틸 이다)이고, R2가 비치환 또는 치환 페닐임을 특징으로 하는 상기 일반식의 화합물과, 이의 락톤, 염과 에스테르 형태인 화합물의 제조방법.
  5. 다음 일반식으로 표시되는 청구범위 1의 화합물에 있어서,
    상기식에서 R5이 식 CH=CH- 또는 R5-CH2=CH2-의 기(여기서 R5는 페닐이다) 이고, R2가 비치환 또는 치환 C1-4알킬 또는 비치환 또는 치환 페닐임을 특징으로 하는 상기 일반식의 화합물과, 이의 락톤, 염과 에스테르 형태인 화합물의 제조방법.
  6. 다음 일반식(Ⅳ)으로 표시되는, 유리산 형태인 중간 화합물
    상기식에서 R'1는 청구범위 1에 표시한 R1과 의미가 같으며, 이때 C12-C16의 알카테트라에닐이나 알카펜타에닐기는 제외된다.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR828202722A 1981-06-18 1982-06-18 5-히드록시-6-티오-치환 알칸산 유도체의 제조방법 KR890000622B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB8118720 1981-06-18
GB8118720 1981-06-18
GB8213211 1982-05-07
GB18213211 1982-05-07
GB8213211 1982-05-07

Publications (2)

Publication Number Publication Date
KR840000483A true KR840000483A (ko) 1984-02-22
KR890000622B1 KR890000622B1 (ko) 1989-03-22

Family

ID=26279835

Family Applications (1)

Application Number Title Priority Date Filing Date
KR828202722A KR890000622B1 (ko) 1981-06-18 1982-06-18 5-히드록시-6-티오-치환 알칸산 유도체의 제조방법

Country Status (23)

Country Link
US (1) US4513005A (ko)
EP (1) EP0068739B1 (ko)
KR (1) KR890000622B1 (ko)
AU (1) AU549814B2 (ko)
BG (1) BG37226A3 (ko)
CA (1) CA1224795A (ko)
CS (1) CS241109B2 (ko)
DD (1) DD202697A5 (ko)
DE (1) DE3261237D1 (ko)
DK (1) DK271682A (ko)
ES (3) ES8307212A1 (ko)
FI (1) FI77847C (ko)
GB (1) GB2101594B (ko)
GR (1) GR76838B (ko)
HU (1) HU192105B (ko)
IE (1) IE53522B1 (ko)
IL (1) IL66056A0 (ko)
NZ (1) NZ200984A (ko)
PH (1) PH23051A (ko)
PL (4) PL240483A1 (ko)
PT (1) PT75058B (ko)
RO (1) RO83706B (ko)
ZA (1) ZA824294B (ko)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2480747A1 (fr) * 1980-04-17 1981-10-23 Roques Bernard Derives d'acides amines et leur application therapeutique
US4537723A (en) * 1982-02-04 1985-08-27 The Upjohn Company Derivatives of leukotrienes A and C
DK130984A (da) * 1983-03-07 1984-09-08 Smithkline Beckman Corp Leukotrien-antagonister
US4775662A (en) * 1983-03-07 1988-10-04 Smithkline Beckman Corporation Leukotriene antagonists
EP0123543B1 (en) * 1983-04-21 1988-02-03 Merck Frosst Canada Inc. Leukotriene antagonists, their production and use and compositions containing them
US4609744A (en) * 1983-04-21 1986-09-02 Merck Frosst Canada Inc. 4-oxo-benzopyran carboxylic acids
US5017583A (en) * 1983-04-21 1991-05-21 Merck Frosst Canada, Inc. Leukotriene antagonists
US4720505A (en) * 1983-06-27 1988-01-19 Merck Frosst Canada, Inc. Leukotriene antagonists
GB8320943D0 (en) * 1983-08-03 1983-09-07 Lilly Industries Ltd Organic compounds
EP0147217A3 (en) * 1983-12-27 1986-08-13 Merck Frosst Canada Inc. Leukotriene antagonists
AU572615B2 (en) 1983-12-27 1988-05-12 Sony Corporation Electrically conductive adhesive sheet circuit board and electrical connection structure
US4761425A (en) * 1983-12-27 1988-08-02 Merck Frosst Canada, Inc. Leukotriene antagonists
US4769386A (en) * 1984-06-18 1988-09-06 Smithkline Beckman Corporation Imidazolylthioalkenoic acids and -alkenols and leukotriene antagonistic composition containing them
US4649215A (en) * 1984-06-28 1987-03-10 Ciba-Geigy Corporation Aliphatic thioethers
US4988716A (en) * 1984-07-18 1991-01-29 Schering Corporation Inhibitors of slow reacting substance of anaphylaxis
US4889873A (en) * 1984-07-18 1989-12-26 Schering Corporation Inhibitors of slow reacting substance of anaphylaxis
US4798842A (en) * 1984-07-18 1989-01-17 Schering Corporation Inhibitors of slow reacting substance of anaphylaxis
US4758594A (en) * 1984-07-18 1988-07-19 Schering Corporation Inhibitors of slow reacting substance of anaphylaxis
GB8502258D0 (en) * 1985-01-30 1985-02-27 Lilly Industries Ltd Organic compounds
AU595193B2 (en) * 1985-04-19 1990-03-29 Smithkline Beckman Corporation Thio substituted acidic derivatives
US4937253A (en) * 1985-04-19 1990-06-26 Smithkline Beecham Corporation Ester prodrugs
US4874792A (en) * 1985-04-19 1989-10-17 Smithkline Beckman Corporation Thiophenyl Alkanoic acids useful as leukotriene antagonists
US4939279A (en) * 1985-04-19 1990-07-03 Smithkline Beecham Corporation Leukotriene antagonists
CA1309557C (en) 1985-06-18 1992-10-27 Robert N. Young Leukotriene antagonists
US4990526A (en) * 1985-06-18 1991-02-05 Merck Frosst Canada, Inc. Leukotriene antagonists, compositions and methods of use thereof
US4696946A (en) * 1985-08-30 1987-09-29 Schering Corporation Topical Treatment of hyperproliferative skin diseases
US4783483A (en) * 1985-10-03 1988-11-08 Ortho Pharmaceutical Corporation Epoxides useful as antiallergic agents
FI864901A (fi) * 1985-12-06 1987-06-07 Ciba Geigy Ag Hydroxitioetrar.
KR870011086A (ko) * 1986-05-29 1987-12-19 벤자민 에프. 램버트 포스포리파제 a₂억제제 및 그의 합성방법
GB8709547D0 (en) * 1987-04-22 1987-05-28 Lilly Industries Ltd Organic compounds
DE3724735A1 (de) * 1987-07-25 1989-02-02 Hoechst Ag Leukotrienantagonisten, verfahren zu ihrer herstellung, ihre anwendung zur behandlung von krankheiten, sowie vorprodukte
DE3724669A1 (de) * 1987-07-25 1989-02-02 Hoechst Ag Leukotrienantagonisten, verfahren zu ihrer herstellung und ihre anwendung zur behandlung von krankheiten
GB8725260D0 (en) * 1987-10-28 1987-12-02 Lilly Industries Ltd Organic compounds
AU610528B2 (en) * 1987-10-29 1991-05-23 Smithkline Beckman Corporation Leukotriene antagonists
GB8807016D0 (en) * 1988-03-24 1988-04-27 Lilly Industries Ltd Organic compounds & their pharmaceutical use
US5073571A (en) * 1988-06-16 1991-12-17 Washington University Method of inhibiting virus
US4954513A (en) * 1988-12-23 1990-09-04 Smithkline Beecham Corporation Leukotriene antagonists
US5149835A (en) * 1989-04-27 1992-09-22 University Of New Mexico Substituted mevalonolactones, and methods for stereoselective preparation thereof and desmethyl homologues thereof
EP0410244A1 (en) * 1989-07-27 1991-01-30 Bayer Ag Leukotriene antagonists
US5238683A (en) * 1989-11-24 1993-08-24 The United States Of America As Represented By The Department Of Health And Human Services Aerosol preparation of glutathione and a method for augmenting glutathione level in lungs
JPH05506662A (ja) * 1990-05-01 1993-09-30 スミスクライン・ビーチャム・コーポレイション 3―ナフチル―3―カルボキシアルキルチオまたはオキシ置換アルカン酸ロイコトリエン拮抗剤
US8026280B2 (en) * 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7842727B2 (en) * 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7312247B2 (en) * 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7057057B2 (en) * 2002-05-22 2006-06-06 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors based on alpha-ketoepoxide compounds
US20030212191A1 (en) * 2002-04-15 2003-11-13 Nippon Bee Chemical Co., Ltd. Aqueous primer coating composition, process for formation of coating film using said composition, and coated article
JP2006508986A (ja) * 2002-11-20 2006-03-16 エルラント ゲネ セラペウチクス エルエルシー ヒストンデアセチラーゼ阻害剤による肺細胞の治療方法
US7964687B2 (en) * 2004-08-31 2011-06-21 Sumitomo Bakelite Company, Ltd. Oxylamino group-containing compound and polymer
US20060160902A1 (en) * 2004-11-08 2006-07-20 Wiech Norbert L Histone deacetylase inhibitors
US7754838B2 (en) * 2006-08-08 2010-07-13 E.I. Du Pont De Nemours And Company Poly(meth)acrylamides and poly(meth)acrylates containing fluorinated amide

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3177227A (en) * 1963-01-30 1965-04-06 Shell Oil Co Lactone production
DE2945497A1 (de) * 1979-03-06 1980-10-09 Degussa Derivate der d-2-hydroxy-4-methylmercaptobuttersaeure, verfahren zu deren herstellung und deren verwendung
US4311645A (en) * 1980-03-24 1982-01-19 Hoffmann-La Roche Inc. Synthesis of SRS-active compounds
FR2479213A1 (fr) * 1980-03-28 1981-10-02 Roussel Uclaf Procede de preparation d'acide pentenoique possedant une fonction aldehyde
JPS57118555A (en) * 1981-01-13 1982-07-23 Ono Pharmaceut Co Ltd Leucotriene-analog compound, its preparation, and leucotriene-biosynthesis inhibiting agent containing said compound as active component
US4352757A (en) * 1981-02-02 1982-10-05 Smithkline Beckman Corporation Process for the preparation of esters of leukotriene A

Also Published As

Publication number Publication date
BG37226A3 (en) 1985-04-15
PH23051A (en) 1989-03-10
AU549814B2 (en) 1986-02-13
FI77847B (fi) 1989-01-31
US4513005A (en) 1985-04-23
IL66056A0 (en) 1982-09-30
ES8404307A1 (es) 1984-05-01
FI822205A0 (fi) 1982-06-18
KR890000622B1 (ko) 1989-03-22
ZA824294B (en) 1983-06-29
ES513221A0 (es) 1983-07-01
HU192105B (en) 1987-05-28
ES8404322A1 (es) 1984-05-01
FI77847C (fi) 1989-05-10
IE53522B1 (en) 1988-12-07
GB2101594A (en) 1983-01-19
CA1224795A (en) 1987-07-28
PL137766B1 (en) 1986-07-31
PT75058A (en) 1982-07-01
RO83706A (ro) 1984-03-15
EP0068739B1 (en) 1984-11-14
ES520671A0 (es) 1984-05-01
FI822205L (fi) 1982-12-19
EP0068739A1 (en) 1983-01-05
DD202697A5 (de) 1983-09-28
AU8500882A (en) 1982-12-23
PL240483A1 (en) 1983-09-12
PL240482A1 (en) 1983-09-12
PT75058B (en) 1985-07-26
DK271682A (da) 1982-12-19
PL240484A1 (en) 1983-09-12
DE3261237D1 (en) 1984-12-20
CS241109B2 (en) 1986-03-13
GR76838B (ko) 1984-09-04
ES8307212A1 (es) 1983-07-01
PL236992A1 (en) 1983-08-15
NZ200984A (en) 1985-01-31
ES520670A0 (es) 1984-05-01
CS456582A2 (en) 1985-07-16
IE821443L (en) 1982-12-18
RO83706B (ro) 1984-03-30
GB2101594B (en) 1985-12-24

Similar Documents

Publication Publication Date Title
KR840000483A (ko) 유기화합물의 개량
KR850000406A (ko) 4-클로로-2-페닐이미다졸-5-아세트산유도체의 제조방법
KR830010060A (ko) 술포네이트 유도체의 제조법
SE8303911L (sv) Jodvinylalkoholforening och forfartande for framstellning av densamma
KR830007686A (ko) 세팔로 스포린 유도체의 제조방법
KR830007626A (ko) 2-(1,4-벤조디옥산-2-일알킬) 이미다졸류의 제조방법
KR860003259A (ko) 벤젠-융합 복소환 화합물의 제조방법
KR840005453A (ko) 펜엠 유도체의 제조방법
KR870003107A (ko) 키산틴 유도체의 제조방법
KR850001766A (ko) 무라밀디펩타이드 활성 에스테르 유도체의 제조방법
KR870010065A (ko) 인산 에스테르 및 그의 제조방법
KR830007613A (ko) 푸란유도체의 제조방법
KR840000578A (ko) 포스포리피드 유도체의 제조방법
KR840004721A (ko) 5-옥소(oxo)-2-피롤리딘프로파노인산 유도체의 제조방법
KR890000508A (ko) 사카로 아스코르브산 에스테르, 그의 제조방법 및 용도
KR850002467A (ko) 6-설폭시페놀 유도체의 제조방법
KR870008912A (ko) 브라시노라이드 유사체의 제조방법
KR880011193A (ko) 23-페닐스테로이드
KR830007509A (ko) 아미노산 유도체의 제조방법
KR840004105A (ko) N,n- 치환된 아졸 카복스 아미드 유도체의 제조방법
KR830004269A (ko) Δ²-1,2,4-트리아졸린-5-온류의 제법
KR910002852A (ko) 디 술피도형 티아민 유도체의 제조방법
KR860004068A (ko) 세펨유도체의 간단한 제조방법
KR920012087A (ko) 벤즈옥사진 유도체의 제조방법
KR840001150A (ko) 치환페닐(티오노)카바메이트의 제조방법